Healthcare Professionals Forum

This scientifically based medical cannabis forum is specifically for healthcare professionals. International and national experts will be presenting essential updates on the endocannabinoid system, clinical data, and the applications and prescribing of medicinal cannabis in medical practice. Essential for GPs, Pharmacists and other healthcare professionals who are critical to improving patient access.

Healthcare Professionals Forum – 11 February

08:50
Dr Rick Acland MBChB, FAFRM (RACP) Director, Burwood & Helius Therapeutics
09:00

Meet and greet your fellow attendees in random breakout rooms in this icebreaker session.

09:20
Bonni Goldstein Medical Director, Canna Centers Wellness & Education
09:40
Brooke van Velden List Member, ACT Party
11:00
  • Cannabis as a medicine
  • Endogenous cannabinoid system
  • Safety data
  • Treating patients in the New Zealand setting
  • Global overview

Dr Mark Hotu Clinical Director, Green Doctors Medicinal Cannabis Clinic
11:30
  • Effectiveness, safety and appropriateness considerations
  • Drug interactions and pharmacogenetics relevant to cannabis with their implications
  • Dosing of CBD and THC
  • Contraindications and adverse effects
  • Presentation of several case studies of New Zealand patients receiving medical cannabis and their clinical responses

Elizabeth Plant Chief Medical Officer, Eqalis
12:00

Graham Gulbransen Cannabis Consultant, Addiction Specialist, General Practitioner, Cannabis Care
13:00
  • Application process in obtaining a licence through the Medicinal Cannabis Agency – tips and tricks
    Facilitator: Andrea Eng, Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
  • EBM4CBD/THC
    Facilitators: Dr Michael Murphy MB, BS, Pharm B.Sc (Hons), Clinical Director, CannaPlus+;
    Dr Afraz Adam MBBS. FRNZCUC, Chief Medical Officer, CannaPlus+
    Extraction technologies
    Steve Tallon Team Leader, Process Engineering Group, Callaghan Innovation
  • Analysis and testing
    Facilitators: Bruce Fraser, New Zealand General Manager, Shimadzu
    Sam Dallas, Analytical Technology Technician, Hill Laboratories
14:40
James Yu Charge pharmacist and Co-Owner , Ngā Hua Pharmacy
15:40
Lionel Marks de Chabris MD Chief Medical Officer, ZYUS Life Sciences
13:00
Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
13:00
Dr Michael Murphy Clinical Director, CannaPlus+
Dr Afraz Adam MBBS. FRNZCUC Chief Medical Officer, CannaPlus+
13:00
Steve Tallon Team Leader, Process Engineering Group, Callaghan Innovation
13:00
Bruce Fraser Team Leader, Process Engineering Group, Callaghan Innovation
Sam Dallas Analytical Technology Technician, Hill Laboratories
13:40
Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
13:40
Dr Afraz Adam MBBS. FRNZCUC Chief Medical Officer, CannaPlus+
Dr. Michael Murphy MB, BS, Pharm B.Sc (Hons) Clinical Director, CannaPlus+
13:40
Steve Tallon Team Leader, Process Engineering Group, Callaghan Innovation
13:40
Bruce Fraser Team Leader, Process Engineering Group, Callaghan Innovation
Sam Dallas Analytical Technology Technician, Hill Laboratories

Accreditation number: 2021/03, Expiry: 06/08/2023. The Health Professional sessions of this conference have been endorsed by The Pharmaceutical Society of New Zealand (PSNZ) and are suitable for Pharmacist’s continuing education.

The “MedCan Summit 2022” has been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for up to 11.25 CME credits for Continuing Professional Development (CPD) purposes.